Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
89 EUR | +0.23% |
|
-.--% | -.--% |
24/06 | SWISS REINSURANCE COMPANY : Barclays reiterates its Neutral rating | ZD |
20/06 | SWISS REINSURANCE COMPANY : Buy rating from JP Morgan | ZD |
Sales 2024 * | 49.33B 46.13B 4,119B | Sales 2025 * | 51.45B 48.12B 4,296B | Capitalization | 36.09B 33.74B 3,013B |
---|---|---|---|---|---|
Net income 2024 * | 3.92B 3.67B 327B | Net income 2025 * | 4.24B 3.96B 354B | EV / Sales 2024 * | 0.85 x |
Net Debt 2024 * | 5.67B 5.3B 473B | Net Debt 2025 * | 5.62B 5.25B 469B | EV / Sales 2025 * | 0.81 x |
P/E ratio 2024 * |
9.48
x | P/E ratio 2025 * |
8.59
x | Employees | 14,719 |
Yield 2024 * |
5.84% | Yield 2025 * |
6.29% | Free-Float | 91.32% |
Latest transcript on Swiss Re Ltd
1 day | +0.23% |
![Extreme 88.68](/images/extremecours_fleche.png)
![Extreme 57.21](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 55 | 01/16/01 | |
John Dacey
DFI | Director of Finance/CFO | 64 | 01/12/01 |
Velina Peneva
CIO | Chief Investment Officer | - | 01/17/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Larry Zimpleman
BRD | Director/Board Member | 72 | 20/18/20 |
Director/Board Member | 68 | 21/17/21 | |
Chairman | 63 | 21/17/21 |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+27.76% | 8.09B | |
+1.51% | 5.97B | |
-7.86% | 4.65B | |
+3.27% | 4.46B | |
+10.77% | 838M | |
+13.67% | 643M | |
+17.86% | 546M | |
+85.25% | 376M | |
+16.00% | 170M |
- Stock Market
- Equities
- SREN Stock
- SR9 Stock